JPMorgan Chase & Co. increases its stake in DINGDANG HEALTH (09886) by approximately 70.1008 million shares at HK$0.71 per share.
After the increase, the latest number of shares held is approximately 71.0093 million shares, and the latest shareholding percentage is 5.72%.
The latest data from the Hong Kong Stock Exchange shows that on October 14, JPMorgan Chase & Co. increased its holdings in DINGDANG HEALTH (09886) by approximately 70.100846 million shares at HK$0.71 per share, for a total amount of approximately HK$49.7716 million. After the increase, its latest holding is approximately 71.0093 million shares, with its latest shareholding percentage at 5.72%.
Related Articles
TRULY INT'L (00732): Subsidiary intends to acquire production and auxiliary equipment for 4.8 billion yen to establish a new e-paper display device factory in China
Shandong Buchang Pharmaceuticals (603858.SH): Qianlie Shutong Capsules have obtained marketing authorization approval in Indonesia.
JINGCHENG MAC (00187) rebounds nearly 20% over two trading days; low-altitude economy and Siasun Robot&Automation concepts fuel stock price?
TRULY INT'L (00732): Subsidiary intends to acquire production and auxiliary equipment for 4.8 billion yen to establish a new e-paper display device factory in China
Shandong Buchang Pharmaceuticals (603858.SH): Qianlie Shutong Capsules have obtained marketing authorization approval in Indonesia.
JINGCHENG MAC (00187) rebounds nearly 20% over two trading days; low-altitude economy and Siasun Robot&Automation concepts fuel stock price?
